![]() |
![]() |
![]() |
![]() |
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Ten countries have reported the presence of contaminated heparin API (active pharmaceutical ingredient) within their boundaries.
They are: Australia, Canada, China, France, Germany, Italy, Japan, The Netherlands, New Zealand, and the United States. Heparin containing the contaminant, oversulfated chondroitin sulfate, has been associated with serious adverse events, including deaths.